Suzhou Industrial Park Heshun Electric's (300141.SZ) controlling shareholder Lvmai Electric plans to reduce its stake by no more than 2%.

19:31 18/03/2026

Hushun Electric (300141.SZ) announced that the company's controlling shareholder, Suzhou Green Pulse Electric Holding (Group) Co., Ltd. (referred to as "Green Pulse Electric"), plans to reduce its holdings of the company's shares through block trades from April 13, 2026 to July 12, 2026, with a maximum of 5.1568 million shares (equivalent to 2.0% of the company's total share capital).

Suzhou Industrial Park Heshun Electric (300141.SZ) announced that its controlling shareholder, Suzhou Greenpulse Electric Holding (Group) Co., Ltd. (referred to as "Greenpulse Electric"), plans to reduce its holdings of the company's shares by no more than 5.1568 million shares (or 2.0% of the total share capital of the company) through block trading from April 13, 2026 to July 12, 2026.

KINTOR PHARMA-B (09939): KX-826 1.0% solution achieves the main endpoint in Phase III critical clinical trial for treating male androgenetic alopecia in Chinese adult males.

QIANHAI HEALTH (00911) releases its performance for the year 2025, with a net profit of HK$5.941 million, representing a year-on-year increase of 353.2%.

SHANGHAI PECHEM (00338) set up a total provision for impairment of 397 million yuan in the 2025 fiscal year.

KINTOR PHARMA-B (09939): KX-826 1.0% solution achieves the main endpoint in Phase III critical clinical trial for treating male androgenetic alopecia in Chinese adult males.

QIANHAI HEALTH (00911) releases its performance for the year 2025, with a net profit of HK$5.941 million, representing a year-on-year increase of 353.2%.

SHANGHAI PECHEM (00338) set up a total provision for impairment of 397 million yuan in the 2025 fiscal year.